Andrew Neill is the founder of Shattuck Labs. Shattuck Labs has raised $331M in total funding. Latest round: IPO. Backed by OrbiMed. Based in Austin, Texas.
Andrew Neill is the Chief Financial Officer at Shattuck Labs, a clinical-stage biotechnology company developing bi-functional fusion proteins for cancer and autoimmune disease. He played a key role in raising $330.5 million through the company's Series B and B-1 financings and initial public offering. Prior to joining Shattuck, Neill co-founded Lumos Pharma, a biopharmaceutical company focused on genetic rare diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library